UNSPSC 51302603: Haloprogin

This classification denotes an anti-infective agent with the molecular formula C9H4Cl3IO, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier AIU7053OWL, chemically known as 2,4,5-trichlorophenyl iodopropargyl ether but generally known as haloprogin, which bears US NIH Compound Identifier 3561. European Medicines Agency schedules Haloprogin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08008MIG.

UNSPSC 51302603 Haloprogin is a Commodity code that covers antifungal medications and topical pharmaceutical agents purchased by state and local public health and emergency response agencies. State and local governments buy haloprogin and related antifungal preparations primarily through fire rescue departments, emergency medical services, and public health clinics for first aid kits, emergency medical supplies, and occupational health programs. The code encompasses individual medications and compounds formulated for treating fungal skin infections in field or clinical settings. Issuing bodies under this code include city fire and rescue departments and municipal procurement offices managing medical supply contracts, typically organized through centralized purchasing for first aid and emergency medical equipment.

Geographic activity centers on Florida, where the City of Tampa Fire Rescue Department recently posted Invitation to Bid 25P00157 (due April 9, 2025) for medical aid supplies including antifungal and antiseptic agents under a $100,000 budget. The solicitation targets a 32-item medical supply list with estimated annual quantities ranging from 1 to 2,700 units per item, structured for an initial one-year award with two optional one-year renewals. Tampa's procurement includes set-aside provisions for City-certified Small Local Business Enterprises (SLBEs) with a 5% bid discount (not to exceed $10,000) and Underutilized Woman and Minority Owned Business Enterprises (U-WMBEs) with a 5% discount (not to exceed $20,000), targeting businesses owned by African American, Hispanic, Asian, Native American, and women entrepreneurs. All medications require a minimum nine-month expiration date from acceptance, and vendors must submit documentation including business licenses, minority business status certifications, and conflict of interest disclosures. The contract permits award by aggregate total or individual line items.